XML 28 R18.htm IDEA: XBRL DOCUMENT v3.21.2

Revenues (Tables)

6 Months Ended

Jun. 30, 2021

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2021 and 2020:

			Three months ended June 30,												Six months ended June 30,
			2021						2020						2021						2020
Products:
Kristalose			$	5,275,065					$	3,477,471					$	8,269,443					$	6,771,433
Vibativ			1,844,936						3,299,507						6,897,179						5,721,708
Caldolor			938,328						1,166,569						2,477,824						2,261,286
Vaprisol			399,952						174,159						1,534,216						382,016
Acetadote			152,781						595,310						269,972						1,308,711
Omeclamox-Pak			(24,109)						10,948						(474,371)						124,371
RediTrex			7,382						—						(24,870)						—
Other revenue			461,148						874,213						643,249						1,359,386
Total net revenues			$	9,055,483					$	9,598,177					$	19,592,642					$	17,928,911

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration